Key Announcements for ONWARD Medical Shareholders in 2025
ONWARD Medical N.V. (Euronext: ONWD and US OTCQX ONWRY) is gearing up for a pivotal moment in its journey. The medical technology company is renowned for developing groundbreaking spinal cord stimulation therapies aimed at restoring movement and improving the quality of life for individuals with spinal cord injuries and other movement disabilities. This year, they are delighted to announce the convocation of their 2025 Annual General Meeting of Shareholders (AGM), set to take place in Amsterdam on June 11, 2025.
Proposed Resolutions for Adoption
During the upcoming AGM, the Board of Directors has put forth several important resolutions for shareholders to consider. These resolutions are crucial for the future direction of the company and include:
- Approval of the annual accounts for the financial year 2024.
- Implementation of the non-binding compensation policy discussion for the financial year 2024.
- Approval of the proposed compensation policy for the board members.
- Releasing directors from liability concerning their actions during the previous financial year.
- Engagement of Ernst & Young Accountants LLP as the external auditor for the year ahead.
- Re-appointment of David Lawrence Marver as executive director.
- Re-appointment of Ian Curtis in the role of non-executive director.
- Appointment of new non-executive directors, including Rahma Samow and Robert Johannes Wilhelmus ten Hoedt.
- Authorization for the Board to issue ordinary shares and grant subscription rights.
- The ability for the Board to acquire ordinary shares for company capital.
These resolutions are designed to strengthen the company's governance framework and ensure strategic flexibility for future growth.
Participation and Record Date
To take part in this critical AGM, all shareholders should be aware of the record date, set for May 14, 2025. This is an important date for ensuring eligibility to participate in the voting process.
Everything You Need for the AGM
All relevant information regarding the AGM, including the convening notice, the agenda, and associated materials, can be found on ONWARD Medical's website. The company is committed to transparency and compliance with all legal requirements, ensuring that shareholders have access to vital information as of April 30, 2025. Shareholders holding US ADRs under ticker ONWRY will also receive a notice from the associated US depositary bank.
About ONWARD Medical
Founded with a vision to change lives, ONWARD Medical is at the forefront of medical technology innovations. With a strong foundation built on years of research and clinical studies, the company has developed its revolutionary ARC Therapy. This technology has received ten Breakthrough Device Designations from the US Food and Drug Administration (FDA), affirming its potential impact in the medical field. The commercial sale of the ARC-EX System in the US marks a significant milestone for the company.
Commitment to Innovation
Currently, ONWARD Medical is also working on an investigational implantable system known as ARC-IM, which could potentially integrate cutting-edge brain-computer interface technologies. With headquarters in the Netherlands and additional facilities in Switzerland and Boston, Massachusetts, ONWARD is well-positioned for ongoing growth and innovation. Both Euronext and OTCQX listings allow for broader shareholder engagement and accessibility.
As we look forward to the AGM, the ongoing work by ONWARD Medical reflects a firm commitment to enhancing the well-being of individuals grappling with mobility challenges. Regular updates and resources can be found on their official website, keeping shareholders informed and engaged with the company's advancements and emerging technologies.
Frequently Asked Questions
What is the date and location of the 2025 AGM for ONWARD Medical?
The 2025 AGM is scheduled for June 11, 2025, in Amsterdam.
What important resolutions will be voted on during the AGM?
Shareholders will vote on various proposals, including the approval of annual accounts, a compensation policy, and reappointments of board members.
How can shareholders participate in the AGM?
Shareholders must ensure they are registered by the record date of May 14, 2025, to participate and vote.
Where can I find more information regarding the AGM and ONWARD Medical?
Detailed information including agendas and notices will be available on ONWARD Medical’s official website.
What is ARC Therapy and its significance?
ARC Therapy is a groundbreaking technology developed by ONWARD Medical aimed at restoring movement capabilities for individuals with spinal cord injuries.
